Skip to main content
NIH funding notice RFA-DA-23-049

HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)

Closed on February 2, 2023.

Posted
July 28, 2022
Close date
February 2, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,846,872 in first-year total cost, median $582,205.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 SKM-M (A1)]3

Most frequent institutions

  1. INSTITUTE FOR CLINICAL RESEARCH, INC.1
  2. UNIVERSITY OF CINCINNATI1
  3. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-DA-23-049 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Towards treatment for the complex patient: investigations of low-intensity focused ultrasound.1UG3DA059407-01LEE, MARYLEGON, WYNNINSTITUTE FOR CLINICAL RESEARCH, INC., DC$778,802ZDA1
2023Improving Buprenorphine Retention with Transcutaneous Auricular Neurostimulation for Patients with Co-occurring Posttraumatic Stress Disorder and Opioid Use Disorder1UG3DA059409-01SPRUNGER, JOEL GREGORYUNIVERSITY OF CINCINNATI, OH$582,205ZDA1
2023Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals with Co-Occurring Internalizing Disorders1UG3DA059414-01ANKER, JUSTIN JACKRINEHART, LINDAUNIVERSITY OF MINNESOTA, MN$485,865ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-23-049: HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional) | ScienceDex | ConductScience